Dr. Rakesh Shrivastava, MD

Dr. Shrivastava practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Shrivastava's NPI, 1043250863, was assigned on June 8, 2006. Dr. Shrivastava holds Oklahoma license 27981.

Dr. Shrivastava's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Shrivastava's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Shrivastava is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is Midwest Hospitalist Group. Dmand AI also links Dr. Shrivastava to 2 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shrivastava practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Shrivastava's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Shrivastava is licensed in Oklahoma.

CMS data shows 3,460 Medicare services from Dr. Shrivastava across 6 procedure codes in 2024, for 688 Medicare patients. Medicare paid $199,415 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 688 Medicare patients who saw Dr. Shrivastava in 2024. The largest group is 65 to 74, with 276 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shrivastava's median patient age at 65, with 58% women.

In 2024, Dr. Shrivastava wrote 47 Medicare Part D claims. 94% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $65 in total drug cost. In 2022, CMS named 307 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 23 out of 100 for Dr. Shrivastava for performance year 2024, reported individually. Dr. Shrivastava accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Shrivastava in 2014. Dr. Shrivastava's most frequent co-authors are Bassem Mounir Chehab, MD, Buddhadeb Dawn, MD and Kavit A. Desouza, MD.

CMS Open Payments shows 47 general payments to Dr. Shrivastava from 15 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 64% of the total. Terumo Medical Corporation paid the most, $446.